PET IMAGING AGENTS FOR THE DIFFERENTIAL DIAGNOSIS OF HYPOXIC TUMORS
Grant number: 1011418 | Funding period: 2011 - 2016
Completed
Abstract
Choosing the best type of treatment from the ever increasing arsenal of chemotherapeutic agents against cancer is of critical importance. Tumor hypoxia requires specialized treatment and patient selection. Current PET imaging agents cannot differentiate between severely and mildly hypoxic tumors. We have found a new agent that can detect mildly hypoxic tumors and the aim of this grant application is to further develop this radiotracer to improve image quality and reliability of the diagnosis.